CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

CADTH Resumes Scientific Advice Activities

Published on: October 7, 2020
Result type: News

CADTH is pleased to announce that we have resumed activities in our Scientific Advice Program. We are once again accepting applications for meetings that will be held in February 2021 and beyond. At this point, all meetings will be held virtually until further notice. Please keep in mind that time periods may fill up quickly and we may not be able to accommodate all requests.

Earlier this year, the Scientific Advice Program was temporarily paused due to the pandemic.

For more information, please consult our website or contact us at scientificadvice@cadth.ca.

About Scientific Advice

The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.